1. Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non- Hodgkin lymphoma 
Koen Van Besien, Rakesh Mehra, Navin Wadehra, Wendy Stock, Issa Khouri, Sergio Giralt, Steve Devine, Amittha Wickrema, David Peace, Jeff Sosman, Jim Gajewski, Richard Champlin 
Biology of Blood and Marrow Transplantation 
Volume 10, Issue 6, Pages (June 2004)
DOI: /j.bbmt

2. Figure 1
Progression-free survival after transplantation for patients who received IL-2-incubated peripheral blood stem cells. The effect of cumulative doses of posttransplantation IL-2 received is shown.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )

3. Figure 2
Progression-free survival after transplantation for patients who received IL-2-incubated peripheral blood stem cells. The effect of maintenance doses of IL-2 is shown.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )

4. Figure 3
Progression-free survival after transplantation. The effect of incubation of peripheral blood stem cells (PBSC) with IL-2 and administration of posttransplantation IL-2 is shown.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )